Briefs: Biocon, Aarti Drugs and Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations

Aster DM Healthcare to launch the Rs. 220 crore Women & Children’s Hospital in Hyderabad

The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care

AstraZeneca Pharma India to launch Palivizumab (Synagis) in October 2024

Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease

Wockhardt's Zaynich cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use

A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use

Briefs: Fermenta Biotech and Family Care Hospitals

Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate

Abbott India inks non-exclusive patent license agreement with Takeda for Vonoprazan

This license will enable Abbott to enhance access to this novel therapy to more patients across India

MGC inks agreement to revolutionize allergy care

Dr. Girish Budhrani recognised with ACOIN Gujarat Chapter Oration

ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology

Merck receives positive EU CHMP opinions for pembrolizumab regimens for gynecologic cancers

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma

Aurobindo Pharma to acquire balance 49% stake in GLS Pharma